Iveric Bio Receives FDA Agreement Under Special Protocol Assessment (SPA) for GATHER2 …,

Similar to the Company’s completed GATHER1 clinical trial, GATHER2 is designed to be an adequate and well-controlled clinical trial which, if positive …, Similar to the Company’s completed GATHER1 clinical trial, GATHER2 is designed to be an adequate and well-controlled clinical trial which, if positive …, Read More

Scroll to Top